{
  "prompt": {
    "guidelineId": "carbetocin-to-prevent-pph-at-cs-uhs-cg-0009-2023-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 1976
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Guideline for Carbetocin Use to Prevent Postpartum Hemorrhage in Cesarean Birth\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not contain a publication year. If you have additional information or a different section of the guideline that includes the year, please provide it\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Guideline for Carbetocin Use in Caesarean Birth:** Carbetocin is recommended to prevent postpartum hemorrhage (PPH) during caesarean birth, replacing oxytocin (not used together). **Administration:** - Give **100 mcg IV over 1 minute** after baby’s birth and cord clamping. - Consider dose reduction in low-risk elective cases. - Never give before birth or exceed 100 mcg. **Roles:** - **Anaesthetist:** Prepares, administers, documents. - **Obstetrician/Midwife:** Monitors uterine tone, lochia, escalates concerns. - **Theatre team:** Maintains stock. **Contraindications:** - Pregnancy/labour prior to birth. - Hypersensitivity to carbetocin/oxytocin. - Serious cardiovascular disease, severe pre-eclampsia/eclampsia. **Cautions:** - Cardiovascular disease, hypotension, hyponatraemia, pre-eclampsia, general anaesthesia. **Adverse Effects:** - Nausea, headache, hypotension, flushing, chest pain, dyspnea. **Training/Monitoring:** - Follow BNF, SPC, NHS Injectable Medicines Guide. - Audit compliance and incident reviews. *References: BNF, SPC carbetocin.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T18-40-31",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"carbetocin-to-prevent-pph-at-cs-uhs-cg-0009-2023-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 1976\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Guideline for Carbetocin Use to Prevent Postpartum Hemorrhage in Cesarean Birth\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not contain a publication year. If you have additional information or a different section of the guideline that includes the year, please provide it\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Guideline for Carbetocin Use in Caesarean Birth:** Carbetocin is recommended to prevent postpartum hemorrhage (PPH) during caesarean birth, replacing oxytocin (not used together). **Administration:** - Give **100 mcg IV over 1 minute** after baby’s birth and cord clamping. - Consider dose reduction in low-risk elective cases. - Never give before birth or exceed 100 mcg. **Roles:** - **Anaesthetist:** Prepares, administers, documents. - **Obstetrician/Midwife:** Monitors uterine tone, lochia, escalates concerns. - **Theatre team:** Maintains stock. **Contraindications:** - Pregnancy/labour prior to birth. - Hypersensitivity to carbetocin/oxytocin. - Serious cardiovascular disease, severe pre-eclampsia/eclampsia. **Cautions:** - Cardiovascular disease, hypotension, hyponatraemia, pre-eclampsia, general anaesthesia. **Adverse Effects:** - Nausea, headache, hypotension, flushing, chest pain, dyspnea. **Training/Monitoring:** - Follow BNF, SPC, NHS Injectable Medicines Guide. - Audit compliance and incident reviews. *References: BNF, SPC carbetocin.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}